Nonunions and the Potential of Stem Cells in Fracture-Healing

Tseng, Susan S.; Lee, Mark A.; Reddi, A. Hari
February 2008
Journal of Bone & Joint Surgery, American Volume;Feb2008 Supplement 1, Vol. 90-A, p92
Academic Journal
Recent progress in human embryonic and adult stem cell research is a cause for much enthusiasm in bone and joint surgery. Stem cells have therapeutic potential in the realm of orthopaedic surgery because of their capacity to self-renew and differentiate into various types of mature cells and tissues, including bone. Because nonunions remain a clinically important problem, there is interest in the use of cell-based strategies to augment fracture repair. Such strategies are being investigated with variations in the model systems, sources of stem cells, and methods for the application and enhancement of osseous healing, including genetic modifications and tissue-engineering. This review highlights the recent progress in the utilization of stem cells and cell-based gene therapy in promoting fracture-healing and its potential utility in the clinical setting.


Related Articles

  • High-yield selection and extraction of two promoter-defined phenotypes of neural stem cells from the fetal human brain. Keyoung, H. Michael; Roy, Neeta S.; Benraiss, Abdellatif; Louissaint, Abner; Suzuki, Akira; Hashimoto, Mitsuhiro; Rashbaum, William K.; Okano, Hideyuki; Goldman, Steven A. // Nature Biotechnology;Sep2001, Vol. 19 Issue 9, p843 

    Neural stem and precursor cells reside in the ventricular lining of the fetal forebrain, and may provide a cellular substrate for brain repair. To selectively identify and extract these cells, we infected dissociated fetal human brain cells with adenoviruses bearing the gene for green...

  • Cell growth: RAC1 sizes up mTOR. Schuldt, Alison // Nature Reviews Molecular Cell Biology;Jun2011, Vol. 12 Issue 6, p343 

    The author discusses the study which observes that conditional deletion of RAC1 from primary mouse embryonic fibroblasts (MEFs), B cells or T cells reduced cell size.

  • JDF NEWS.  // Countdown;Summer2002, Vol. 23 Issue 3, p48 

    Reports global developments related to medicine as of July 2002. Support of Australian Prime Minister John Howard for embryonic stem cell research; Sponsorship of the 'Roaring '20s Remembered' gala by UnitedHealthcare; Launch of the Arizona Chapter's Promise Gala 2002.

  • Editorial. Knuuttila, Tarja; Hyssalo, Sampsa // Science Studies;Jun2007, Vol. 20 Issue 1, p3 

    The article discusses various reports published within the issue, including "From Core Set to Assemblage: On the Dynamics of Exclusion and Inclusion in the Failure to Derive Beta Cells from Embryonic Stem Cells," by Mike Michael and colleagues, and "Effects of 'Mode 2'-Related Policy on the...

  • Non-injection methods for the production of embryonic stem cell-embryo chimaeras. Wood, Stephen A.; Allen, Nick D. // Nature;9/2/1993, Vol. 365 Issue 6441, p87 

    Contrasts the morulae aggregation and blastocyst injection techniques for the production of germline chimaeras. Same percentage of germline chimaeras for both methods; Pluripotency of the embryonic stem cells as the most critical parameter; Savings in time and equipment when using aggregation...

  • pluripotent, pluripotential.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1809 

    The definitions of the medical terms "pluripotent" or "pluripotential," which pertains to an embryonic cell that can form various types of cells, or having a number of different functions, are presented.

  • blastoderm.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p276 

    An encyclopedia entry for blastoderm, a disk of cells, is presented.

  • Development: A new move for PRMT5. Huddleston, Joanna E. // Nature Reviews Molecular Cell Biology;Feb2011, Vol. 12 Issue 2, p76 

    The article discusses research study on the development of the protein Arg N-methyltransferase 5 (PRMT5) which references the study "Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency," by W. W. Tee and colleagues in the 2010 issue of "Genes...

  • Europe dithers over regulations for stem-cell research. Abbott, Alison // Nature;12/11/2003, Vol. 426 Issue 6967, p595 

    Reports on Europe's debate on research using embryonic stem cells. Failure of research ministers of the European Union's (EU) member states to agree on whether EU funding should be available for research using human embryonic stem cells; Expiration of the moratorium on research funding;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics